Upload
kimberly-stephens
View
29
Download
3
Embed Size (px)
DESCRIPTION
Bertram et al. (2005) , NEJM, 352:884-894. Bertram et al. (2005) , NEJM, 352:884-894. Bertram et al. (2005) , NEJM, 352:884-894. Bertram et al. (2005) , NEJM, 352:884-894. Ubiquilin 1 Gene (UBQLN1) Differential RNA splicing gives two different mRNA variants:. 10. 11. 11. 10. 1. 2. 3. 4. - PowerPoint PPT Presentation
Citation preview
Bertram et al. (2005) , NEJM, 352:884-894.
Bertram et al. (2005) , NEJM, 352:884-894.
Bertram et al. (2005) , NEJM, 352:884-894.
Bertram et al. (2005) , NEJM, 352:884-894.
1 2 3 4 5 6 7 8 9 1110
1 2 3 4 5 6 7 9 1110
Transcript Variant 1: All 11 exons
Transcript Variant 2: Exon 8 excluded
Ubiquilin 1 Gene (UBQLN1)
Differential RNA splicing gives twodifferent mRNA variants:
Transcript Variant 2Transcript Variant 1
AD Cases Controls
AD Cases have more mRNA variant 2 than Controls.
Genotype CC(High Risk)
Genotype TC(Medium Risk)
Genotype TT(Low Risk)
The C allele gives more “high risk”mRNA than the T allele
Transcript Variant 2Transcript Variant 1
Conclusion:
•A C/T allele in the intron after exon 8 influences RNA splicing.
•The C allele results in more transcript variant 2 than the T allele.
•The more transcript 2, the greater the risk for Alzheimers.